HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

María José Ramirez Sánchez Selected Research

Tyrosine Kinase Inhibitors

5/2015Bosutinib shows low cross intolerance, in chronic myeloid leukemia patients treated in fourth line. Results of the Spanish compassionate use program.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


María José Ramirez Sánchez Research Topics

Disease

1Philadelphia Chromosome
05/2015
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
05/2015

Drug/Important Bio-Agent (IBA)

1bosutinibIBA
05/2015
1Tyrosine Kinase InhibitorsIBA
05/2015